In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| 10-Q | 10-Q | | 8-K | 10-Q | 10-Q | 10-K | 10-Q |
Assets | | | | | | | | |
Current: | | | | | | | | |
Cash and cash equivalents | 5.1 | 6.4 | | 17.2 | 19.0 | 44.3 | 37.2 | 45.8 |
Restricted cash | 0.1 | 0.3 | | | 0.4 | 0.5 | 0.5 | 0.4 |
Accounts receivable, net | 2.6 | 2.6 | | 2.6 | 3.4 | 2.6 | 2.2 | 2.2 |
Prepaids, deposits and other receivables | 3.2 | 3.8 | | | 4.7 | 2.8 | 2.7 | 3.8 |
Inventories, net | 7.5 | 8.0 | | 16.7 | 16.7 | 16.2 | 15.4 | 14.1 |
Total current assets | 18.4 | 21.1 | | 40.5 | 44.3 | 69.2 | 60.4 | 68.1 |
Investment – Cansativa | 5.8 | 5.8 | | | 5.7 | 1.4 | 1.5 | 1.5 |
Property, plant and equipment, net of accumulated depreciation of $7,990 and $7,120 for June 30, 2023 and December 31, 2022, respectively | 13.1 | 13.5 | | 29.0 | 29.5 | 30.1 | 30.9 | 29.7 |
Assets held for sale - Land | 1.5 | 1.5 | | | | | | |
Intangible assets, net | 3.0 | 3.2 | | 3.5 | 22.7 | 22.9 | 23.1 | 23.3 |
Operating lease right-of-use assets, net | 1.0 | 1.1 | | | 3.2 | 3.7 | | |
Other non-current assets | 0.1 | 0.1 | | 0.1 | 0.0 | 0.0 | 0.3 | 0.1 |
Total Assets | 42.8 | 46.2 | | 81.4 | 105.5 | 127.2 | 116.2 | 141.1 |
|
Liabilities and Stockholders' equity | | | | | | | | |
Liabilities | | | | | | | | |
Current: | | | | | | | | |
Accounts payable | 2.3 | 1.8 | | 2.3 | 3.2 | 4.4 | 4.0 | 2.9 |
Accrued expenses and other current liabilities | 3.1 | 3.8 | | 2.4 | 2.7 | 3.1 | | 2.4 |
Loans and borrowings, current portion | 0.5 | 0.5 | | | 0.5 | 1.3 | 0.9 | |
Warrant liability | 0.2 | 0.2 | | | 0.4 | 1.7 | 2.2 | 13.7 |
Operating lease liabilities, current portion | 0.7 | 0.6 | | | 1.5 | 1.6 | | |
Deferred revenue | 0.8 | 1.0 | | | 1.3 | 1.3 | 0.7 | 1.3 |
Total current liabilities | 7.6 | 7.8 | | 8.2 | 8.6 | 27.5 | 27.2 | 32.6 |
Loans and borrowing — long-term | 0.9 | 1.0 | | | 1.6 | | | |
Operating lease liabilities — long-term | 0.4 | 0.6 | | | 1.9 | 2.3 | | |
Other long-term liabilities | 0.0 | 0.0 | | 0.8 | 0.8 | 0.9 | 0.4 | 0.7 |
Total Liabilities | 8.9 | 9.5 | | 11.9 | 20.9 | 44.8 | 43.4 | 53.5 |
|
Contingencies and commitments | | | | | | | | |
Shareholders’ equity | | | | | | | | |
Additional paid-in capital | 222.5 | 221.8 | | 221.6 | 216.5 | 213.3 | 187.5 | 178.4 |
Accumulated deficit | -188.6 | -185.0 | | -152.1 | -131.9 | -130.9 | -114.7 | -90.7 |
Total shareholders' equity | 33.9 | 36.8 | | 69.5 | 84.6 | 82.4 | 72.8 | 87.7 |
Total liabilities and shareholders' equity | 42.8 | 46.2 | | 81.4 | 105.5 | 127.2 | 116.2 | 141.1 |